Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aurelie Fantou"'
Autor:
Nicolas Chapelle, Aurelie Fantou, Thomas Marron, Ephraim Kenigsberg, Miriam Merad, Jerome C. Martin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Immunotherapy drugs are transforming the clinical care landscape of major human diseases from cancer, to inflammatory diseases, cardiovascular diseases, neurodegenerative diseases and even aging. In polygenic immune-mediated inflammatory diseases (IM
Externí odkaz:
https://doaj.org/article/f35748a78e854d07b6d0bbad699cccad
Autor:
Lucille Quénéhervé, Caroline Trang-Poisson, Aurélie Fantou, Mathurin Flamant, Tony Durand, Guillaume Bouguen, Jérémy Bregeon, Thibauld Oullier, Morgane Amil, Marie Dewitte, Stéphanie Bardot, Stéphanie Blandin, Cécile Braudeau, Marie-Anne Vibet, Régis Josien, Michel Neunlist, Arnaud Bourreille
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0298313 (2024)
AimsIn patients with ulcerative colitis (UC), no biomarker is available to help the physician to choose the most suitable biotherapy. The primary objective of this pilot study was to assess the feasibility of identification of α4β7- and TNF-express
Externí odkaz:
https://doaj.org/article/c6db894b75ea40feb89acade98ba4eea
Autor:
Aurélie Fantou, Eric Lagrue, Thomas Laurent, Laurence Delbos, Stéphanie Blandin, Anne Jarry, Gaëlle Beriou, Cécile Braudeau, Nina Salabert, Eros Marin, Aurélie Moreau, Juliette Podevin, Arnaud Bourreille, Régis Josien, Jérôme C. Martin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Crohn’s disease (CD), a form of inflammatory bowel disease (IBD), is characterized by impaired epithelial barrier functions and dysregulated mucosal immune responses. IL-22 binding protein (IL-22BP) is a soluble inhibitor regulating IL-22 bioactivi
Externí odkaz:
https://doaj.org/article/78649f341ab54ec6a0451b9ea26a891b